ArticleMarine biotechnology (New York, N.Y.)2026
Integrated Transcriptomic and Metabolomic Analyses Reveal Molecular Mechanism in Hybrid Crucian Carp (Carassius cuvieri♀ × Carassius auratus Red var♂) after Gut Infection with Aeromonas hydrophila L3-3.
Article in Marine biotechnology (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Aeromonas hydrophila is an important etiologic agent that can pose a significant threat to the health of aquatic animals. Nonetheless, the immunometabolic crosstalk of hybrid crucian carp (WR, Carassius cuvieri♀ × Carassius auratus red var♂) after gut infection remains largely understudied. In this study, WRs receiving gut infection with A. hydrophila L3-3 displayed increased levels of tissue damage and antioxidant collapse. Then, multiomics analyses indicated that fatty acid metabolism may be considered as the crucial metabolic pathways in midgut of WRs following gut infection with A. hydrophila L3-3, with FFA(14:1) and Ser-Ile-Asn-Lys acting as pivotal biomarkers. These findings may clarify the immunometabolic response and identify the molecular regulatory mechanisms in gut tract of WRs after A. hydrophila L3-3 infection.
Indexed as
Identifiers
41663608What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.